The mining syringe of the brand “Wegovy” is sold in the Pharmacy Purchase in Mitte. The slimming “Wegovy” syringe has been available in Germany for a year.
Jens Kalaene | Photo alliance | Getty images
CVS health On Thursday, he said that he would considerably be expanding access to the successful successful Wegovy weight loss medication for patients covered by his pharmacy service manager, Caremark.
From July 1, Caremark deprives Wegovy on his forms – or lists of covered medication – making it the preferred GLP -1 medication for obesity. This decision is part of a new partnership between Caremark and the manufacturer of Wegovy, Novo NordiskDepending on the release of the results of the first quarter of CVS.
Caremark will also abandon the Zepbound weight loss medication from its standard forms on this date, in one blow for its manufacturer, Eli Lillysaid a spokesperson for CVS, CNBC. They said these standard forms are the most common among Caremark customers, representing tens of millions of patients.
Eligible patients covered by Caremark who are currently taking Zepbound will be able to go to Wegovy, the spokesperson said.
Novo Nordisk’s shares increased by around 1% on Thursday after the announcement, while Eli Lilly’s shares fell 8%.
This occurs while Novo Nordisk is working to stimulate access to Wegovy now that he is no longer broken in the United States in partnership with Caremark, one of the largest pharmacy services in the country, could help the drug manufacturer to reach even more patients.
Caremark reduces drugs with manufacturers on behalf of insurance plans and creates lists of medication, or forms, which are covered by insurance pharmacies and reimburses for prescriptions.
Caremark will make the drug available to its members at “a more affordable price”. The PBM has negotiated a net price lower than Wegovy on Zepbound on its standard forms, offering savings to customers who opt for these plans, said CVS spokesperson.
But Caremark customers, who are employers and unions, “individually determine the share of these savings on Wegovy shared with its members via lower bonuses or lower copays at the pharmacy counter,” said the spokesperson.
Separately, any patient who has no insurance coverage for Wegovy or another GLP-1 can still buy the Novo Nordisk medication smuggling for $ 499 in one of the 9,000 CVS pharmacies nationally, added the spokesperson.
In its winning press release, CVS said it was the first retail pharmacy partnership with the new direct pharmacy to the NOVO Nordisk consumer, to exempt Wegovy to pregnant patients. Novocare offers Wegovy at this price lower than cash patients, who may find it difficult to assume the price of about $ 1,000 of the drug before insurance and other discounts.
Caremark will also combine Wegovy with additional support on lifestyle, such as personalized nutrition plans, as part of the CVS weight management program.
The announcement comes as the Danish drug manufacturer rushes to capture more patients now than many composition pharmacies are legally linked to the manufacture of cheaper and not approved versions of Wegovy, with rare exceptions.
“We do not know at this stage how the migration of pharmacies made up in other pharmacy circles will occur,” the president of the CVS health group, Prem Shah said on Thursday. “But we expect there obviously an advantage by opening 9,000 stores, or 9,000 possibilities for patients to be able to obtain the medication.”
Dave Moore, executive vice-president of the American operations of Novo Nordisk, said Thursday in a separate statement that it is our responsibility to continue working with others through the American health system to find innovative opportunities to meet the needs of these patients and to connect them with an authentic and approved way by the FDA … practically and affordable. “”